Regulatory Updates
Sep 25, 2026•1 min read
FDA Approves Teva Generic FAMCICLOVIR (ANDA 077487) for Oral Use
The FDA has approved Teva Pharmaceuticals’ ANDA 077487 for the oral tablet formulation of FAMCICLOVIR, available in 125 mg, 250 mg and 500 mg strengths.
Regulatory Updates
Sep 16, 2026•1 min read
FDA Approves ANDA203834 for Acyclovir Oral Tablets
The FDA has approved ANDA203834 for prescription oral acyclovir tablets (400 mg and 800 mg) manufactured by Camber Pharmaceuticals and sponsored by Hetero Labs.
Regulatory Updates
Aug 30, 2026•1 min read
Hyundai Bio's antiviral candidate Xafty shows negative genotoxicity in GLP micronucleus test
Hyundai Bio reports that its broad‑spectrum antiviral candidate Xafty (XAFTY) achieved a negative genotoxicity result in a GLP micronucleus assay, adding safety data ahead of the AIR‑V trial.